SlideShare a Scribd company logo
1 of 47
Benign Bone Tumors
Dr Anand Ranjan Dev
Dept of Orthopaedics RKCH
LECTURE ON TUMORS CONTINUED...
W.H.O. CLASSIFICATION OF BONE TUMOURS (2002-
Revised)
I. OSTEOGENIC TUMOURS
BENIGN
•OSTEOMA
•OSTEOID OSTEOMA
•OSTEOBLASTOMA
MALIGNANT
•OSTEOSARCOMA
II. CARTILAGE FORMING TUMOURS
Benign
•Chondroma
•Osteochondroma
•Chondromyxoid fibroma
•Chondroblastoma
Malignant
•Chondrosarcoma
III. FIBROGENIC
Fibrosarcoma
IV. FIBROHISTIOCYTIC
•Benign fibrous histiocytoma
VI. HEMATOPOETIC
• Lymphoma
• Multiple Myeloma
VII. GCT
VIII. NOTOCHORDAL TUMOURS
IX. VASCULAR Benign
•Hemangioma
•Lymphangioma
•Malignant fibrous histiocytoma •Glomangioma
Malignant
V. NEUROECTODERMAL •Angiosarcoma
•Ewing’s sarcoma
XI. MISCELLANEOUS
• Bone cysts-simple or aneurysmal
• Fibrous dysplasia-mono or polystotic
•Reparative giant-cell granuloma (e.G.
Epulis)
• Fibrous cortical defect
• Eosinophilic granuloma
• Non ossfying fibroma
•Osteitis fibrosa cystica (brown
Surgical Staging System for Musculoskeletal Tumors (Enneking and MSTS)
Benign:
1 Latent G 0 T 0 M 0
2 Active G 0 T 0 M 0
3 Aggressive G 0 T 1-2 M 0-1
Surgical Grade (for malignant tumors only)
G1: Broder’s 1 &2
G2: Broder’s 3&4
Site:
T 1: Intracompartmental (Confined within limits of periosteum)
T 2: Extracompartmental (Breach in an adjacent joint cartilage, bone
cortex or periosteum, fascia lata, quadriceps, and joint capsule)
Metastasis:
M 0: No identifiable skip lesions or distant metastases.
M 1: Any skip lesions, regional lymph nodes, or distant metastases.
Discussion:
Benign tumor staging uses Arabic numbers (1,2,3)
Malignant tumors identified with Roman numerals and a letter (Ia, Ib,
IIa, IIb, IIIa, IIIb)
STAGING-
Enneking Stage-1 (latent stage)
remains static or heals spontaneously Eg: NOF
•intra capsular
•no growth
•well defined margins
•thick reactive bone
•not expanding cortex
Stage-2 (active)
progressive growth but limited by natural barriers Eg: Simple bone cyst
•intra capsular
•actively growing
•well defined margins
•thin rim of reactive bone
•cortical expansion with thinning
Stage 3 (aggressive)
Progressive growth not limited by natural barriers eg: GCT
•Extracapsular
•Break through reactive bone/cortex
OSTEOMA
Benign bony outgrowth of
membranous bones.
Multiple osteomas are associated
with
Gardner's syndrome
Highest incidence in the sixth
decade
Male: female is 3:1
Asymptomatic
Excision if symptomatic
OSTEOID OSTEOMA
•Commonest benign
osseous tumour
•Common in 1st& 2nd
decade of life
•10% of all benign bone
tumours
• M:F – 2:1
•SITE: diaphysis,
metaphysis of long bones
CLINICAL FEATURES
Dull pain, worse at night (night cries) & responds to salicylates (
aspirin)
Swelling uncommon
Tenderness
RADIOLOGICAL FEATURES
A sharp round or oval lesion.
Less than 2 cm in diameter.
Radiolucent nidus surrounded by reactive sclerosis
Nidus- osteolytic/partially/entirely calcified
Investigations
CT SCAN:
Nidus is best localized with CT (1 mm cuts)
Bull‟s eye lesion
BONE SCAN: Tc99
Due to intense radioisotope uptake by nidus and decreased uptake by
surrounding sclerotic bone, a double density image is created that is
typical of osteoid osteoma.
Headlight in fog appearance
Management
Course: Self limiting
On maturation, ossify and merge with surrounding bone
No reports of malignant transformation till date
Treatment:
Conservative - not recommended because of severity of pain
Surgical: En Bloc resection, Burr down
Percutaneous radiofrequency ablation (PRA)
OSTEOBLASTOMA
Benign osseous tumour similar to
osteoid osteoma
Progressive growth, absence of
reactive perifocal bone formation
2nd, 3rd decade.
M > F
Sites: vertebrae- posterior
elements
Pain, long duration
CT scan- „cotton wool‟ if calcified
ENCHONDROMA
AGE: Most common between 2nd
& 4th decades
SITES: Short tubular bones of hand
(phalanges and metacarpals),
followed by femur, humerus and
ribs
RADIOGRAPHS: well circumscribed
distinct area of rarefaction,
expands the cortex
Calcification in older lesions –
spotty /punctate
Management
Asymptomatic lesions - follow-up with serial radiographs
Symptomatic – PET Scan or biopsy to r/o any malignancy
Curettage and bone grafting
Wide excision to avoid recurrence
Pathologic fractures are allowed to heal with closed treatment,
curettage and bone grafting is then required after fracture healing.
OLLIERS DISEASE
Multiple enchondromatosis
Non-hereditary disorder common in children
Affects metaphysis of long bones
Presentation – bony swellings leads to thickening and shortening and
deformities
Diagnosis
On radiographs, streaks of low density are seen projecting through the
diaphyses into the epiphyses of the long bones, due to ectopic cartilage
deposits. With age, the cartilage may calcify in the typical "snowflake"
pattern.
MAFFUCCI SYNDROME
• hereditary familial disease
• multiple enchondroma and cavernous haemangioma
Treatment:
The deformities are managed surgically to preserve the function of the
limb.
Osteochondroma
Also known as:
Osteocartilaginous Exostosis
Cartilage capped bony
projection on external surface of
bone.
Commonest benign tumour of
bone.
Lesion has its own growth
plate, usually stops growing at
skeletal maturity.
AGE GROUPS: first two decades
SEX PREDILECTION: M:F-1.5:1
SITES OF PREDILECTION: Around the knee(40%)
and proximal humerus.
LOCATION: Metaphysis/diaphysis of long bones.
Asymptomatic
Pain: Mechanical, Ischemic necrosis, Perilesional
bursitis, Fracture of stalk, Malignancy <1%
Growth disturbance of the extremity
Block to joint motion
No growth after skeletal maturity
X RAY
Pedunculated / sessile – exophytic
metaphysis / diaphysis
Marrow and cortices of lesion continuous with bone
Directed away from growing end
Cartilage cap not seen on x ray
PATHOGENESIS:
Herniation of a fragment of growth plate through periosteal bone cuff
Misdirected growth of that portion of physis
HISTOLOGY:
Cartilage cap resembles layers of the normal growth plate
The cartilage is more disorganized than normal
Binucleate chondrocytes in lacunae
Covered with a thin layer of periosteum.
Cartilage cap 1-3 mm thick, thicker in children
SIGNS OF MALIGNANCY:
>2 cm after skeletal maturity indicates possible malignant
transformation
Growth spurt of lesion beyond skeletal maturity
Development of soft tissue with calcifications
Dispersed calcifications within the cartilaginous cap
Treatment
Observe
Delay excision until later adolescence
 Pain, deformity, nerve palsy, movement restriction
HEREDITARY MULTIPLE EXOSTOSES (H.M.E)
Also known as: Multiple Exostoses, Diaphyseal aclasis
Autosomal dominant hereditary disorder, 10% no
family history. EXT1,2,3 genes
Knees, ankles and shoulders are most frequently affected.
Knobby appearance, Short stature
Forearm deformity, Tibio-fibular synostosis, Genu valgum, Coxa valga
Rx - Excision of symptomatic exostosis
Correction of deformity and limb length
discrepancy
CHONDROBLASTOMA
ALSO KNOWN AS: Codman’s
Tumour
Arises from immature cells of
epiphyseal cartilage
AGE GROUPS: 10 to 20 yrs.
SEX PREDILECTION: Males more
affected than females.
SITES OF PREDILECTION: Proximal
part of the tibia, proximal part of
the humerus and femur.
LOCATION: Epiphysis/ apophysis
SYMPTOMS: Pain and local swelling
of joint without h/o trauma
RADIOGRAPHS:
Well defined oval lytic lesion
Sclerotic margin
Epiphysis
Eccentric
Cottonwool calcification
HPE: Chicken-wire calcification
CHONDROMYXOID FIBROMA
Rare benign bone tumour (<1%)
Chondroid tumour with myxoid
and fibrous elements
AGE GROUPS: Adolescents and
young adults.
SEX PREDILECTION: Males more
affected than females (2:1).
SITES OF PREDILECTION: Lower
extremities usually proximal tibia.
LOCATION: Metaphysis.
SYMPTOMS: Peripherally located
mass with local pain and swelling.
NONOSSIFYING FIBROMA
•Solitary
•Eccentric
•radiolucent, ovoid, bubbly
• metaphysis
Treatment
In most cases of NOF, treatment is
not required. If left alone, Over
time, the NOF will fill in with bone.
Most NOFs disappear by the time a
person reaches the early 20s. Large
size and symptoms can indicate
that the bone is weak and is likely
to fracture, even with very little
force.
Curettage
The most common method of treating NOFs is with curettage.
Bone Graft
After curettage, fill the hole with a bone graft . You may also use a bone
cement mixture to fill the hole.
FIBROUS DYSPLASIA
•Developmental anomaly of bone
formation.
C/F :
3-15 yrs
M:F 1:1
Bowing deformities and
pathologic fractures
Café-au-lait spots are present in
30% of patients.
Vision and hearing loss but it's a
rare complication.
Arthritis.
 Cancer. Fibrous dysplasia with Shepherd‟s crook
deformity and pathological fracture
TYPES:
Monostotic fibrous dysplasia (solitary lesion): 70-80%
Polyostotic fibrous dysplasia (multiple bones)20-30% McCune
Albright syndrome: Polyostotic fibrous dysplasia, Endocrine
dysfunction: precocious puberty, hyperthyroidism, Café-au-lait spots
(coast of Maine)
GIANT CELL TUMOUR (OSTEOCLASTOMA)
INCIDENCE : 5% of biopsied
primary bone tumors.
CLINICAL FEATURES: 5Es- Elderly
Epiphysis
Eccentric
Expansive
Egg shell crackling
Radiological Signs:
Lytic lesion
Epiphysis
Narrow zone of transition
Thinning of cortex
Honey comb appearance
Soap bubble appearance
35
Radiological grading
(campanacci)
• Grade1(Quiescent): well defined margin with
surrounding sclerosis; cortex: slightly thinned
but not deformed
• Grade2(Active): well defined margin, lack
sclerosis; cortex-thinned and expanded
• Grade3(Aggressive): ill defined margin, often
with cortical destruction and soft tissue
extension
36
Jaffe’s 3 Histological grades of GCT
• Grade I tumor; benign, low aggressive behavior: dense
layer of huge giant cells with up to 100 or more nuclei,
almost covering the tumor tissue proper of mononuclear
cells.
• Grade II tumor; benign highly aggressive behavior:
Considerable reduction in the size and number of giant
cells, and mononuclear cells may be pleomorphic to
some degree.
• Grade III tumors; malignant: Giant cells are further
reduced in number and there is an increase in
pleomorphic mononuclear cells.
DIFFERENTIAL DIAGNOSIS:
GCT has to be differentiated from giant cell variants.
Unicameral bone cyst
Aneurysmal bone cyst
Non-ossifying fibroma
Chondroblastoma
GCT of hyperparathyroidism (Brown tumor)
39
Malignancy in GCT
Histology: high grade spindle cell sarcoma with or
without osteoid
Vacular invasion, soft tissue extension & high
mitotic activity do not establish malignancy
No residual giant cell tumor
Primary cases: conventional GCT present
Prognosis of primary better than secondary ones
40
Treatment Strategies
 1. curettage
 2. curettage and cytotoxic agents such as 5%phenol,zinc
chloride,70% alcohol, and H2O2.
 3. curettage and a physical adjuvant
(polymethylmethacrylate, liquid nitrogen and cryosurgery)
 4. curettage & bone grafting
 5. radical resection
 6. radiation therapy
 7. amputation
 8. embolization: in unresectable tumors.
When to do what?
Curettage , bone cement
(adjuvant therapy)
and
k wire fixation
Curettage and Bone Grafting
High speed burr
Endoprosthesis
T – Construct reconstruction
47
Thank you !

More Related Content

Similar to anandbenignbonetumors-150803083037-lva1-app6892.pptx

D. Firas lecture minimum muhadharaty require
D. Firas lecture minimum muhadharaty requireD. Firas lecture minimum muhadharaty require
D. Firas lecture minimum muhadharaty require
hussainAltaher
 
Malignant bone Tumors,Radiology
Malignant bone Tumors,RadiologyMalignant bone Tumors,Radiology
Malignant bone Tumors,Radiology
Docdipz123
 
bonetumors-161023202240 (1).pdf
bonetumors-161023202240 (1).pdfbonetumors-161023202240 (1).pdf
bonetumors-161023202240 (1).pdf
ShyamChadsania
 

Similar to anandbenignbonetumors-150803083037-lva1-app6892.pptx (20)

D. Firas lecture minimum muhadharaty require
D. Firas lecture minimum muhadharaty requireD. Firas lecture minimum muhadharaty require
D. Firas lecture minimum muhadharaty require
 
2023 FIBROUS DYSPLASIA DENTAL.pptx
2023 FIBROUS DYSPLASIA  DENTAL.pptx2023 FIBROUS DYSPLASIA  DENTAL.pptx
2023 FIBROUS DYSPLASIA DENTAL.pptx
 
Malignant bone Tumors,Radiology
Malignant bone Tumors,RadiologyMalignant bone Tumors,Radiology
Malignant bone Tumors,Radiology
 
Benign tumors and tumor like lesions
Benign tumors and tumor like lesionsBenign tumors and tumor like lesions
Benign tumors and tumor like lesions
 
bonetumors-161023202240 (1).pdf
bonetumors-161023202240 (1).pdfbonetumors-161023202240 (1).pdf
bonetumors-161023202240 (1).pdf
 
bonetumors-161023202240.pdf
bonetumors-161023202240.pdfbonetumors-161023202240.pdf
bonetumors-161023202240.pdf
 
Bone tumors
Bone tumorsBone tumors
Bone tumors
 
Common benign and malignant bone tumors
Common benign and malignant bone tumorsCommon benign and malignant bone tumors
Common benign and malignant bone tumors
 
Bone Tumors
Bone TumorsBone Tumors
Bone Tumors
 
Mixed rl adnd ro lesions / dental courses
Mixed rl adnd ro lesions / dental coursesMixed rl adnd ro lesions / dental courses
Mixed rl adnd ro lesions / dental courses
 
bonetumors-161023202240.pptx
bonetumors-161023202240.pptxbonetumors-161023202240.pptx
bonetumors-161023202240.pptx
 
Benign bone tumours
Benign bone tumoursBenign bone tumours
Benign bone tumours
 
FOLs
FOLs FOLs
FOLs
 
Bone Tumor
Bone TumorBone Tumor
Bone Tumor
 
Cystic lesion of bones
Cystic lesion of bonesCystic lesion of bones
Cystic lesion of bones
 
Bone tumor
Bone tumorBone tumor
Bone tumor
 
Bone tumor dr patnaik
Bone tumor dr patnaikBone tumor dr patnaik
Bone tumor dr patnaik
 
Benign tumors in orthopaedics
Benign tumors in orthopaedicsBenign tumors in orthopaedics
Benign tumors in orthopaedics
 
Sclerotic
ScleroticSclerotic
Sclerotic
 
Benign bone tumors
Benign bone tumorsBenign bone tumors
Benign bone tumors
 

More from asdgja

malignantbonetumor-190228134628.pptx
malignantbonetumor-190228134628.pptxmalignantbonetumor-190228134628.pptx
malignantbonetumor-190228134628.pptx
asdgja
 
malignantbonetumours-170608150210.pptx
malignantbonetumours-170608150210.pptxmalignantbonetumours-170608150210.pptx
malignantbonetumours-170608150210.pptx
asdgja
 
genetic disorders of bone 1.pptx
genetic disorders of bone 1.pptxgenetic disorders of bone 1.pptx
genetic disorders of bone 1.pptx
asdgja
 
umy-benignbonetumors-140824003220-phpapp01.pptx
umy-benignbonetumors-140824003220-phpapp01.pptxumy-benignbonetumors-140824003220-phpapp01.pptx
umy-benignbonetumors-140824003220-phpapp01.pptx
asdgja
 
benignbonetumors-140418025726-phpapp01.pptx
benignbonetumors-140418025726-phpapp01.pptxbenignbonetumors-140418025726-phpapp01.pptx
benignbonetumors-140418025726-phpapp01.pptx
asdgja
 
bcfinalextracredit-161220220220.pptx
bcfinalextracredit-161220220220.pptxbcfinalextracredit-161220220220.pptx
bcfinalextracredit-161220220220.pptx
asdgja
 
marfansyndrome-220129064039.pptx
marfansyndrome-220129064039.pptxmarfansyndrome-220129064039.pptx
marfansyndrome-220129064039.pptx
asdgja
 
67740e9c-b09b-41ae-b013-49542858c4c0-150528193201-lva1-app6892.pptx
67740e9c-b09b-41ae-b013-49542858c4c0-150528193201-lva1-app6892.pptx67740e9c-b09b-41ae-b013-49542858c4c0-150528193201-lva1-app6892.pptx
67740e9c-b09b-41ae-b013-49542858c4c0-150528193201-lva1-app6892.pptx
asdgja
 
gaucherdisease-170222084210.pptx
gaucherdisease-170222084210.pptxgaucherdisease-170222084210.pptx
gaucherdisease-170222084210.pptx
asdgja
 
mucopolysachridosis-150903060000-lva1-app6892 (1).pptx
mucopolysachridosis-150903060000-lva1-app6892 (1).pptxmucopolysachridosis-150903060000-lva1-app6892 (1).pptx
mucopolysachridosis-150903060000-lva1-app6892 (1).pptx
asdgja
 
motor neuron disease.pptx
motor neuron disease.pptxmotor neuron disease.pptx
motor neuron disease.pptx
asdgja
 

More from asdgja (11)

malignantbonetumor-190228134628.pptx
malignantbonetumor-190228134628.pptxmalignantbonetumor-190228134628.pptx
malignantbonetumor-190228134628.pptx
 
malignantbonetumours-170608150210.pptx
malignantbonetumours-170608150210.pptxmalignantbonetumours-170608150210.pptx
malignantbonetumours-170608150210.pptx
 
genetic disorders of bone 1.pptx
genetic disorders of bone 1.pptxgenetic disorders of bone 1.pptx
genetic disorders of bone 1.pptx
 
umy-benignbonetumors-140824003220-phpapp01.pptx
umy-benignbonetumors-140824003220-phpapp01.pptxumy-benignbonetumors-140824003220-phpapp01.pptx
umy-benignbonetumors-140824003220-phpapp01.pptx
 
benignbonetumors-140418025726-phpapp01.pptx
benignbonetumors-140418025726-phpapp01.pptxbenignbonetumors-140418025726-phpapp01.pptx
benignbonetumors-140418025726-phpapp01.pptx
 
bcfinalextracredit-161220220220.pptx
bcfinalextracredit-161220220220.pptxbcfinalextracredit-161220220220.pptx
bcfinalextracredit-161220220220.pptx
 
marfansyndrome-220129064039.pptx
marfansyndrome-220129064039.pptxmarfansyndrome-220129064039.pptx
marfansyndrome-220129064039.pptx
 
67740e9c-b09b-41ae-b013-49542858c4c0-150528193201-lva1-app6892.pptx
67740e9c-b09b-41ae-b013-49542858c4c0-150528193201-lva1-app6892.pptx67740e9c-b09b-41ae-b013-49542858c4c0-150528193201-lva1-app6892.pptx
67740e9c-b09b-41ae-b013-49542858c4c0-150528193201-lva1-app6892.pptx
 
gaucherdisease-170222084210.pptx
gaucherdisease-170222084210.pptxgaucherdisease-170222084210.pptx
gaucherdisease-170222084210.pptx
 
mucopolysachridosis-150903060000-lva1-app6892 (1).pptx
mucopolysachridosis-150903060000-lva1-app6892 (1).pptxmucopolysachridosis-150903060000-lva1-app6892 (1).pptx
mucopolysachridosis-150903060000-lva1-app6892 (1).pptx
 
motor neuron disease.pptx
motor neuron disease.pptxmotor neuron disease.pptx
motor neuron disease.pptx
 

Recently uploaded

Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...
Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...
Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...
Cara Menggugurkan Kandungan 087776558899
 
Physiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdfPhysiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdf
MedicoseAcademics
 
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan CytotecJual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
jualobat34
 

Recently uploaded (20)

VIP ℂall Girls Kothanur {{ Bangalore }} 6378878445 WhatsApp: Me 24/7 Hours Se...
VIP ℂall Girls Kothanur {{ Bangalore }} 6378878445 WhatsApp: Me 24/7 Hours Se...VIP ℂall Girls Kothanur {{ Bangalore }} 6378878445 WhatsApp: Me 24/7 Hours Se...
VIP ℂall Girls Kothanur {{ Bangalore }} 6378878445 WhatsApp: Me 24/7 Hours Se...
 
TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...
TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...
TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...
 
Drug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptxDrug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptx
 
The Clean Living Project Episode 23 - Journaling
The Clean Living Project Episode 23 - JournalingThe Clean Living Project Episode 23 - Journaling
The Clean Living Project Episode 23 - Journaling
 
Circulatory Shock, types and stages, compensatory mechanisms
Circulatory Shock, types and stages, compensatory mechanismsCirculatory Shock, types and stages, compensatory mechanisms
Circulatory Shock, types and stages, compensatory mechanisms
 
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptxCreeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
 
Cardiac Output, Venous Return, and Their Regulation
Cardiac Output, Venous Return, and Their RegulationCardiac Output, Venous Return, and Their Regulation
Cardiac Output, Venous Return, and Their Regulation
 
Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...
Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...
Cara Menggugurkan Kandungan Dengan Cepat Selesai Dalam 24 Jam Secara Alami Bu...
 
Part I - Anticipatory Grief: Experiencing grief before the loss has happened
Part I - Anticipatory Grief: Experiencing grief before the loss has happenedPart I - Anticipatory Grief: Experiencing grief before the loss has happened
Part I - Anticipatory Grief: Experiencing grief before the loss has happened
 
Physicochemical properties (descriptors) in QSAR.pdf
Physicochemical properties (descriptors) in QSAR.pdfPhysicochemical properties (descriptors) in QSAR.pdf
Physicochemical properties (descriptors) in QSAR.pdf
 
Physiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdfPhysiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdf
 
Dr. A Sumathi - LINEARITY CONCEPT OF SIGNIFICANCE.pdf
Dr. A Sumathi - LINEARITY CONCEPT OF SIGNIFICANCE.pdfDr. A Sumathi - LINEARITY CONCEPT OF SIGNIFICANCE.pdf
Dr. A Sumathi - LINEARITY CONCEPT OF SIGNIFICANCE.pdf
 
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptxANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
 
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan CytotecJual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
 
VIP ℂall Girls Arekere Bangalore 6378878445 WhatsApp: Me All Time Serviℂe Ava...
VIP ℂall Girls Arekere Bangalore 6378878445 WhatsApp: Me All Time Serviℂe Ava...VIP ℂall Girls Arekere Bangalore 6378878445 WhatsApp: Me All Time Serviℂe Ava...
VIP ℂall Girls Arekere Bangalore 6378878445 WhatsApp: Me All Time Serviℂe Ava...
 
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATROMOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
 
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
 
Top 10 Most Beautiful Chinese Pornstars List 2024
Top 10 Most Beautiful Chinese Pornstars List 2024Top 10 Most Beautiful Chinese Pornstars List 2024
Top 10 Most Beautiful Chinese Pornstars List 2024
 
HISTORY, CONCEPT AND ITS IMPORTANCE IN DRUG DEVELOPMENT.pptx
HISTORY, CONCEPT AND ITS IMPORTANCE IN DRUG DEVELOPMENT.pptxHISTORY, CONCEPT AND ITS IMPORTANCE IN DRUG DEVELOPMENT.pptx
HISTORY, CONCEPT AND ITS IMPORTANCE IN DRUG DEVELOPMENT.pptx
 
Intro to disinformation and public health
Intro to disinformation and public healthIntro to disinformation and public health
Intro to disinformation and public health
 

anandbenignbonetumors-150803083037-lva1-app6892.pptx

  • 1. Benign Bone Tumors Dr Anand Ranjan Dev Dept of Orthopaedics RKCH LECTURE ON TUMORS CONTINUED...
  • 2. W.H.O. CLASSIFICATION OF BONE TUMOURS (2002- Revised) I. OSTEOGENIC TUMOURS BENIGN •OSTEOMA •OSTEOID OSTEOMA •OSTEOBLASTOMA MALIGNANT •OSTEOSARCOMA II. CARTILAGE FORMING TUMOURS Benign •Chondroma •Osteochondroma •Chondromyxoid fibroma •Chondroblastoma Malignant •Chondrosarcoma
  • 3. III. FIBROGENIC Fibrosarcoma IV. FIBROHISTIOCYTIC •Benign fibrous histiocytoma VI. HEMATOPOETIC • Lymphoma • Multiple Myeloma VII. GCT VIII. NOTOCHORDAL TUMOURS IX. VASCULAR Benign •Hemangioma •Lymphangioma •Malignant fibrous histiocytoma •Glomangioma Malignant V. NEUROECTODERMAL •Angiosarcoma •Ewing’s sarcoma XI. MISCELLANEOUS • Bone cysts-simple or aneurysmal • Fibrous dysplasia-mono or polystotic •Reparative giant-cell granuloma (e.G. Epulis) • Fibrous cortical defect • Eosinophilic granuloma • Non ossfying fibroma •Osteitis fibrosa cystica (brown
  • 4.
  • 5. Surgical Staging System for Musculoskeletal Tumors (Enneking and MSTS) Benign: 1 Latent G 0 T 0 M 0 2 Active G 0 T 0 M 0 3 Aggressive G 0 T 1-2 M 0-1 Surgical Grade (for malignant tumors only) G1: Broder’s 1 &2 G2: Broder’s 3&4 Site: T 1: Intracompartmental (Confined within limits of periosteum) T 2: Extracompartmental (Breach in an adjacent joint cartilage, bone cortex or periosteum, fascia lata, quadriceps, and joint capsule) Metastasis: M 0: No identifiable skip lesions or distant metastases. M 1: Any skip lesions, regional lymph nodes, or distant metastases. Discussion: Benign tumor staging uses Arabic numbers (1,2,3) Malignant tumors identified with Roman numerals and a letter (Ia, Ib, IIa, IIb, IIIa, IIIb)
  • 6. STAGING- Enneking Stage-1 (latent stage) remains static or heals spontaneously Eg: NOF •intra capsular •no growth •well defined margins •thick reactive bone •not expanding cortex
  • 7. Stage-2 (active) progressive growth but limited by natural barriers Eg: Simple bone cyst •intra capsular •actively growing •well defined margins •thin rim of reactive bone •cortical expansion with thinning
  • 8. Stage 3 (aggressive) Progressive growth not limited by natural barriers eg: GCT •Extracapsular •Break through reactive bone/cortex
  • 9. OSTEOMA Benign bony outgrowth of membranous bones. Multiple osteomas are associated with Gardner's syndrome Highest incidence in the sixth decade Male: female is 3:1 Asymptomatic Excision if symptomatic
  • 10. OSTEOID OSTEOMA •Commonest benign osseous tumour •Common in 1st& 2nd decade of life •10% of all benign bone tumours • M:F – 2:1 •SITE: diaphysis, metaphysis of long bones
  • 11. CLINICAL FEATURES Dull pain, worse at night (night cries) & responds to salicylates ( aspirin) Swelling uncommon Tenderness
  • 12. RADIOLOGICAL FEATURES A sharp round or oval lesion. Less than 2 cm in diameter. Radiolucent nidus surrounded by reactive sclerosis Nidus- osteolytic/partially/entirely calcified
  • 13. Investigations CT SCAN: Nidus is best localized with CT (1 mm cuts) Bull‟s eye lesion BONE SCAN: Tc99 Due to intense radioisotope uptake by nidus and decreased uptake by surrounding sclerotic bone, a double density image is created that is typical of osteoid osteoma.
  • 14. Headlight in fog appearance
  • 15. Management Course: Self limiting On maturation, ossify and merge with surrounding bone No reports of malignant transformation till date Treatment: Conservative - not recommended because of severity of pain Surgical: En Bloc resection, Burr down Percutaneous radiofrequency ablation (PRA)
  • 16. OSTEOBLASTOMA Benign osseous tumour similar to osteoid osteoma Progressive growth, absence of reactive perifocal bone formation 2nd, 3rd decade. M > F Sites: vertebrae- posterior elements Pain, long duration CT scan- „cotton wool‟ if calcified
  • 17. ENCHONDROMA AGE: Most common between 2nd & 4th decades SITES: Short tubular bones of hand (phalanges and metacarpals), followed by femur, humerus and ribs RADIOGRAPHS: well circumscribed distinct area of rarefaction, expands the cortex Calcification in older lesions – spotty /punctate
  • 18. Management Asymptomatic lesions - follow-up with serial radiographs Symptomatic – PET Scan or biopsy to r/o any malignancy Curettage and bone grafting Wide excision to avoid recurrence Pathologic fractures are allowed to heal with closed treatment, curettage and bone grafting is then required after fracture healing.
  • 19. OLLIERS DISEASE Multiple enchondromatosis Non-hereditary disorder common in children Affects metaphysis of long bones Presentation – bony swellings leads to thickening and shortening and deformities Diagnosis On radiographs, streaks of low density are seen projecting through the diaphyses into the epiphyses of the long bones, due to ectopic cartilage deposits. With age, the cartilage may calcify in the typical "snowflake" pattern.
  • 20. MAFFUCCI SYNDROME • hereditary familial disease • multiple enchondroma and cavernous haemangioma Treatment: The deformities are managed surgically to preserve the function of the limb.
  • 21. Osteochondroma Also known as: Osteocartilaginous Exostosis Cartilage capped bony projection on external surface of bone. Commonest benign tumour of bone. Lesion has its own growth plate, usually stops growing at skeletal maturity. AGE GROUPS: first two decades SEX PREDILECTION: M:F-1.5:1
  • 22. SITES OF PREDILECTION: Around the knee(40%) and proximal humerus. LOCATION: Metaphysis/diaphysis of long bones. Asymptomatic Pain: Mechanical, Ischemic necrosis, Perilesional bursitis, Fracture of stalk, Malignancy <1% Growth disturbance of the extremity Block to joint motion No growth after skeletal maturity
  • 23. X RAY Pedunculated / sessile – exophytic metaphysis / diaphysis Marrow and cortices of lesion continuous with bone Directed away from growing end Cartilage cap not seen on x ray
  • 24. PATHOGENESIS: Herniation of a fragment of growth plate through periosteal bone cuff Misdirected growth of that portion of physis HISTOLOGY: Cartilage cap resembles layers of the normal growth plate The cartilage is more disorganized than normal Binucleate chondrocytes in lacunae Covered with a thin layer of periosteum. Cartilage cap 1-3 mm thick, thicker in children
  • 25. SIGNS OF MALIGNANCY: >2 cm after skeletal maturity indicates possible malignant transformation Growth spurt of lesion beyond skeletal maturity Development of soft tissue with calcifications Dispersed calcifications within the cartilaginous cap Treatment Observe Delay excision until later adolescence  Pain, deformity, nerve palsy, movement restriction
  • 26. HEREDITARY MULTIPLE EXOSTOSES (H.M.E) Also known as: Multiple Exostoses, Diaphyseal aclasis Autosomal dominant hereditary disorder, 10% no family history. EXT1,2,3 genes Knees, ankles and shoulders are most frequently affected. Knobby appearance, Short stature Forearm deformity, Tibio-fibular synostosis, Genu valgum, Coxa valga Rx - Excision of symptomatic exostosis Correction of deformity and limb length discrepancy
  • 27. CHONDROBLASTOMA ALSO KNOWN AS: Codman’s Tumour Arises from immature cells of epiphyseal cartilage AGE GROUPS: 10 to 20 yrs. SEX PREDILECTION: Males more affected than females. SITES OF PREDILECTION: Proximal part of the tibia, proximal part of the humerus and femur. LOCATION: Epiphysis/ apophysis SYMPTOMS: Pain and local swelling of joint without h/o trauma
  • 28. RADIOGRAPHS: Well defined oval lytic lesion Sclerotic margin Epiphysis Eccentric Cottonwool calcification HPE: Chicken-wire calcification
  • 29. CHONDROMYXOID FIBROMA Rare benign bone tumour (<1%) Chondroid tumour with myxoid and fibrous elements AGE GROUPS: Adolescents and young adults. SEX PREDILECTION: Males more affected than females (2:1). SITES OF PREDILECTION: Lower extremities usually proximal tibia. LOCATION: Metaphysis. SYMPTOMS: Peripherally located mass with local pain and swelling.
  • 30. NONOSSIFYING FIBROMA •Solitary •Eccentric •radiolucent, ovoid, bubbly • metaphysis Treatment In most cases of NOF, treatment is not required. If left alone, Over time, the NOF will fill in with bone. Most NOFs disappear by the time a person reaches the early 20s. Large size and symptoms can indicate that the bone is weak and is likely to fracture, even with very little force.
  • 31. Curettage The most common method of treating NOFs is with curettage. Bone Graft After curettage, fill the hole with a bone graft . You may also use a bone cement mixture to fill the hole.
  • 32. FIBROUS DYSPLASIA •Developmental anomaly of bone formation. C/F : 3-15 yrs M:F 1:1 Bowing deformities and pathologic fractures Café-au-lait spots are present in 30% of patients. Vision and hearing loss but it's a rare complication. Arthritis.  Cancer. Fibrous dysplasia with Shepherd‟s crook deformity and pathological fracture
  • 33. TYPES: Monostotic fibrous dysplasia (solitary lesion): 70-80% Polyostotic fibrous dysplasia (multiple bones)20-30% McCune Albright syndrome: Polyostotic fibrous dysplasia, Endocrine dysfunction: precocious puberty, hyperthyroidism, Café-au-lait spots (coast of Maine)
  • 34. GIANT CELL TUMOUR (OSTEOCLASTOMA) INCIDENCE : 5% of biopsied primary bone tumors. CLINICAL FEATURES: 5Es- Elderly Epiphysis Eccentric Expansive Egg shell crackling Radiological Signs: Lytic lesion Epiphysis Narrow zone of transition Thinning of cortex Honey comb appearance Soap bubble appearance
  • 35. 35 Radiological grading (campanacci) • Grade1(Quiescent): well defined margin with surrounding sclerosis; cortex: slightly thinned but not deformed • Grade2(Active): well defined margin, lack sclerosis; cortex-thinned and expanded • Grade3(Aggressive): ill defined margin, often with cortical destruction and soft tissue extension
  • 36. 36 Jaffe’s 3 Histological grades of GCT • Grade I tumor; benign, low aggressive behavior: dense layer of huge giant cells with up to 100 or more nuclei, almost covering the tumor tissue proper of mononuclear cells. • Grade II tumor; benign highly aggressive behavior: Considerable reduction in the size and number of giant cells, and mononuclear cells may be pleomorphic to some degree. • Grade III tumors; malignant: Giant cells are further reduced in number and there is an increase in pleomorphic mononuclear cells.
  • 37.
  • 38. DIFFERENTIAL DIAGNOSIS: GCT has to be differentiated from giant cell variants. Unicameral bone cyst Aneurysmal bone cyst Non-ossifying fibroma Chondroblastoma GCT of hyperparathyroidism (Brown tumor)
  • 39. 39 Malignancy in GCT Histology: high grade spindle cell sarcoma with or without osteoid Vacular invasion, soft tissue extension & high mitotic activity do not establish malignancy No residual giant cell tumor Primary cases: conventional GCT present Prognosis of primary better than secondary ones
  • 40. 40 Treatment Strategies  1. curettage  2. curettage and cytotoxic agents such as 5%phenol,zinc chloride,70% alcohol, and H2O2.  3. curettage and a physical adjuvant (polymethylmethacrylate, liquid nitrogen and cryosurgery)  4. curettage & bone grafting  5. radical resection  6. radiation therapy  7. amputation  8. embolization: in unresectable tumors.
  • 41. When to do what? Curettage , bone cement (adjuvant therapy) and k wire fixation
  • 42. Curettage and Bone Grafting
  • 45. T – Construct reconstruction
  • 46.